Richard A. Larson to Investigational New Drug Application
This is a "connection" page, showing publications Richard A. Larson has written about Investigational New Drug Application.
Connection Strength
0.142
-
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. Transpl Infect Dis. 2016 Oct; 18(5):785-790.
Score: 0.142
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.